Xometry, Inc. (NASDAQ:XMTR) Shares Sold by Bellecapital International Ltd.

Bellecapital International Ltd. trimmed its holdings in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 2.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 516,512 shares of the company's stock after selling 13,765 shares during the quarter. Xometry comprises approximately 2.5% of Bellecapital International Ltd.'s portfolio, making the stock its 15th biggest position. Bellecapital International Ltd. owned approximately 1.03% of Xometry worth $12,871,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. State of Wyoming boosted its position in shares of Xometry by 8.2% in the 4th quarter. State of Wyoming now owns 8,876 shares of the company's stock valued at $379,000 after purchasing an additional 676 shares during the period. Rhumbline Advisers lifted its stake in Xometry by 5.7% in the fourth quarter. Rhumbline Advisers now owns 59,367 shares of the company's stock valued at $2,533,000 after buying an additional 3,180 shares during the last quarter. BNP Paribas Financial Markets acquired a new stake in shares of Xometry in the fourth quarter valued at approximately $259,000. Truist Financial Corp purchased a new position in shares of Xometry during the fourth quarter worth approximately $225,000. Finally, Principal Financial Group Inc. acquired a new position in shares of Xometry in the 4th quarter valued at $1,258,000. 97.31% of the stock is currently owned by hedge funds and other institutional investors.

Xometry Stock Performance

NASDAQ:XMTR traded down $1.99 during mid-day trading on Friday, reaching $30.15. The stock had a trading volume of 582,682 shares, compared to its average volume of 618,407. Xometry, Inc. has a twelve month low of $11.08 and a twelve month high of $45.33. The business has a 50 day simple moving average of $28.90 and a 200 day simple moving average of $31.31. The firm has a market capitalization of $1.53 billion, a price-to-earnings ratio of -28.71 and a beta of 0.84. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.55 and a current ratio of 4.59.

Insiders Place Their Bets

In related news, Director Emily Rollins sold 10,041 shares of the company's stock in a transaction on Friday, May 9th. The stock was sold at an average price of $30.70, for a total transaction of $308,258.70. Following the transaction, the director now owns 11,105 shares of the company's stock, valued at $340,923.50. This represents a 47.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Randolph Altschuler sold 9,331 shares of the firm's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $25.16, for a total value of $234,767.96. Following the completion of the sale, the chief executive officer now directly owns 328,934 shares of the company's stock, valued at approximately $8,275,979.44. This trade represents a 2.76% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 24,644 shares of company stock worth $666,660. Company insiders own 9.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on XMTR shares. Royal Bank of Canada increased their price target on shares of Xometry from $32.00 to $36.00 and gave the stock a "sector perform" rating in a research note on Wednesday, May 7th. JPMorgan Chase & Co. increased their target price on shares of Xometry from $36.00 to $38.00 and gave the stock an "overweight" rating in a research note on Tuesday, June 3rd. The Goldman Sachs Group raised their price target on Xometry from $30.00 to $33.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Cantor Fitzgerald upped their price objective on Xometry from $20.00 to $21.00 and gave the company an "underweight" rating in a research note on Wednesday, May 7th. Finally, Citigroup decreased their price objective on Xometry from $46.00 to $39.00 and set a "buy" rating for the company in a research report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, Xometry presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.78.

Xometry Company Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.